BRCA Consenting Seminar Outcomes Proposal




Ma, Canice

Journal Title

Journal ISSN

Volume Title



Ovarian cancer is the most fatal women’s cancer where every day, five Canadian women will die from the illness. Recent advances in the hereditary understanding of the disease have shown a significant role of the BRCA gene where this genetic marker can indicate an increase in cancer risk, as well as serving as a possible targeted treatment option for women. Identifying a mutation with the BRCA gene can also provide an opportunity for genetic testing to be performed for relatives, which can allow for preventative approaches to be taken. The purpose of this study is to evaluate the use of a seminar model to provide education and obtain consent for genetic testing for individuals with ovarian cancer. The investigators hypothesize that the seminar model is effective in providing education and obtaining consent, resulting in decreased wait times from diagnosis to test results while increasing the number of eligible individuals completing genetic testing.



Counseling Outcome Scale, Genetic testing, Group education, Informed consent, Nursing, Ovarian cancer, Seminar model